---
sidebar_position: 80
---
           <p class="stitle-article-norm">Implementing acts</p>
   <p class="norm">The Commission may, by means of implementing acts, 
establish the detailed arrangements and procedural aspects necessary for
 the implementation of this Chapter as regards the following:</p>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(a)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">harmonised electronic forms for the application
 for clinical investigations and their assessment as referred to in 
Articles&nbsp;70 and 78, taking into account specific categories or 
groups of devices;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(b)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">the functioning of the electronic system referred to in <a href='../CHAPTER VI/Article 73 - Electronic system on clinical investigations'> Article 73</a>;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(c)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">harmonised electronic forms for the 
notification of PMCF investigations as referred to in 
<a href='../CHAPTER VI/Article 74 - Clinical investigations regarding devices bearing the CE marking'> Article 74</a>(1), and of substantial modifications as referred to in 
<a href='../CHAPTER VI/Article 75 - Substantial modifications to clinical investigations'> Article 75</a>;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(d)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">the exchange of information between Member&nbsp;States as referred to in <a href='../CHAPTER VI/Article 76 - Corrective measures to be taken by Member States and information exchange between Member States'> Article 76</a>;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(e)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">harmonised electronic forms for the reporting 
of serious adverse events and device deficiencies as referred to in 
<a href='../CHAPTER VI/Article 80 - Recording and reporting of adverse events that occur during clinical investigations'> Article 80</a>;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(f)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">the timelines for the reporting of serious 
adverse events and device deficiencies, taking into account the severity
 of the event to be reported as referred to in <a href='../CHAPTER VI/Article 80 - Recording and reporting of adverse events that occur during clinical investigations'> Article 80</a>;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(g)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">uniform application of the requirements 
regarding the clinical evidence or data needed to demonstrate compliance
 with the general safety and performance requirements set out in 
Annex&nbsp;I.</p>
      </div>
   </div>
   <p class="norm">The implementing acts referred to in the first 
paragraph&nbsp;shall be adopted in accordance with the examination 
procedure referred to in <a href='../CHAPTER X/Article 114 - Committee procedure'> Article 114</a>(3).</p>